Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · IEX Real-Time Price · USD
1.380
-0.080 (-5.48%)
Mar 28, 2024, 4:00 PM EDT - Market closed
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for UNCY stock have an average target of 4.63, with a low estimate of 3.00 and a high estimate of 6.00. The average target predicts an increase of 235.51% from the current stock price of 1.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for UNCY stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +226.09% | Mar 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +226.09% | Mar 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +226.09% | Mar 5, 2024 |
Noble Capital Markets | Noble Capital Markets | Buy Initiates $6 | Buy | Initiates | $6 | +334.78% | Feb 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4.5 | Strong Buy | Reiterates | $4.5 | +226.09% | Dec 19, 2023 |
Financial Forecast
Revenue This Year
522.75K
Revenue Next Year
2.55M
from 522.75K
Increased by 387.80%
EPS This Year
-1.26
from -1.20
EPS Next Year
-0.42
from -1.26
Revenue Forecast
Revenue | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | 735,000 | 10.5M | 89.0M | 209.3M | 151.6M | 192.9M |
Avg | 522,750 | 2.6M | 37.0M | 111.7M | 93.1M | 125.1M |
Low | n/a | n/a | 2.0M | 19.3M | 37.5M | 60.2M |
Revenue Growth
Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | 1,908.6% | 3,389.1% | 466.0% | 35.7% | 107.2% |
Avg | - | 387.8% | 1,350.0% | 202.1% | -16.6% | 34.3% |
Low | - | - | -22.4% | -47.8% | -66.4% | -35.4% |
EPS Forecast
EPS | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | -1.29 | -0.25 | 0.37 | 0.57 | 0.22 | 0.78 |
Avg | -1.26 | -0.42 | -0.23 | 0.01 | 0.07 | 0.54 |
Low | -1.22 | -0.59 | -0.77 | -0.51 | -0.08 | 0.31 |
EPS Growth
EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|---|
High | - | - | - | - | 2,061.8% | 1,071.9% |
Avg | - | - | - | - | 550.0% | 715.4% |
Low | - | - | - | - | - | 373.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.